Pfizer's COVID Vaccine <br />for Kids Under 5 , Moves Closer to FDA Approval .<br />Pfizer announced on June 1 that its application to the Food and Drug Administration (FDA) for the vaccine was complete.<br />Pfizer announced on June 1 that its application to the Food and Drug Administration (FDA) for the vaccine was complete.<br />The three-dose vaccine is for children between the ages of six months and five years.<br />Pfizer released a statement detailing the application.<br />Pfizer and BioNTech completed a rolling application to the U.S. Food and Drug Administration (FDA) for emergency use authorization (EUA)... , Pfizer Statement, via ABC News.<br />... of the 3-µg [microgram] dose of the Pfizer-BioNTech COVID-19 Vaccine.., Pfizer Statement, via ABC News.<br />... for children 6 months through <br />4 years of age (also referred to as <br />6 months to under 5 years of age) on June 1, 2022, Pfizer Statement, via ABC News.<br />Pfizer reported an 80 percent effectiveness rate in children in May.<br />The FDA also released a statement on June 1, confirming that the agency had accepted the Pfizer application.<br />We recognize parents are anxious to have their young children vaccinated against COVID-19... , FDA Statement, via ABC News.<br />... and while the FDA cannot predict how long its evaluation of the data and information <br />will take, , FDA Statement, via ABC News.<br />... we will review any EUA request we receive as quickly as possible using a science-based approach, FDA Statement, via ABC News.<br />According to a poll conducted by the <br />Kaiser Family Foundation in April of this year.<br />... just 18 percent of parents intend to have their children vaccinated once the vaccine is approved.<br />27 percent of parents stated that they will "definitely not" vaccinate their children against COVID
